Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009.
From 2017 to 2018, he was the CEO of Genentech. [6] While at Genentech, he developed its immunology and ophthalmology divisions, managed the sales of Rituxan, Raptiva, and Xolair, and directed Roche's late-stage portfolio committee for nearly four years, where he was responsible for determining late-stage clinical trial advancements. [6]
The overall economic impact of the bioscience industry in Ohio, including healthcare, amounted to $148.2 billion in 2007, representing 15.7% of Ohio's economic output. [5] Half of the biotech industry is located in northeast Ohio, with 574 firms, while central and southern Ohio are home to around 200 each.
Episcopal Diocese of Southern Ohio, Episcopal Church diocese, includes parishes, schools, covenants, community organizations; Great Lakes and Ohio River Division, U.S. Army Corps of Engineers, operates as a regional business center with seven districts that covers 335,000 sq. mi. in 17 states, utilizing about 5,000 team members [2]
Genentech had been able to manufacture, receive federal approval for, and market its own product, marking the successful execution of Swanson's plan to form out of Genentech a self sustainable biotech firm. [5] [6] [8] Swanson left his position as CEO in 1990, taking on the position of chairman until his retirement from Genentech in 1996. [5 ...
Geneva is located 45 miles (72 km) east of Cleveland and 55 miles (89 km) west of Erie, Pennsylvania. The city is bordered to the north, east and west by Geneva Township and by Harpersfield Township to the south. The Grand River flows around Geneva to the south in Harpersfield and to the west in Lake County.
Fluor acquired shares of Genentech Inc. in 1981, [54] and it bought a 10 percent interest in a smelter and refinery facility in Gresik, Indonesia in 1995 for $550 million. In 1994, it invested $650 million with the Beacon Group Energy Investment fund to finance energy projects. [ 35 ]
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.